Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.

International journal of molecular sciences - 23 Aug 2023

Rahman Aminur, Roy Kumar Jyotirmoy, Deb Gautam Kumar, Ha Taehyeong, Rahman Saifur, Aktar Mst Khudishta, Ali Md Isahak, Kafi Md Abdul, Choi Jeong-Woo

Abstract excerpt

This review discusses receptor-binding domain (RBD) mutations related to the emergence of various SARS-CoV-2 variants, which have been highlighted as a major cause of repetitive clinical waves of COVID-19. Our perusal of the literature reveals that most variants were able to escape neutralizing antibodies developed after immunization or natural exposure, pointing to the need for a sustainable technological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to COVID-19

Share to Lipids

Share to Mutation

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 37685938
DOI: 10.3390/ijms241713130
PMCID: PMC10488153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.PMID 37685938Read ↗

SARS-CoV-2 Virus-like Particles with Plasmonic Au Cores and S1-Spike Protein CoronasSemantic proximity Read ↗

Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses.Semantic proximity Read ↗

Virus-like Plasmonic Nanoprobes for Quick Analysis of Antiviral Efficacy and Mutation-Induced Drug Resistance.Semantic proximity Read ↗

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2Semantic proximity Read ↗

Spherical Neutralizing Aptamer Inhibits SARS-CoV-2 Infection and Suppresses Mutational Escape.Semantic proximity Read ↗

A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potentialSemantic proximity Read ↗

Genetically engineered MRI-trackable extracellular vesicles as SARS-CoV-2 mimetics for mapping ACE2 binding <i>in vivo</i>Semantic proximity Read ↗

Respiratory mucosal administration of DNA aptamer nanomaterials protects against antigenically diverse SARS-CoV-2 variantsSemantic proximity Read ↗

Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogensSemantic proximity Read ↗

Peptide derived nanobody inhibits entry of SARS-CoV-2 variantsSemantic proximity Read ↗

Peptide Antidotes to SARS-CoV-2 (COVID-19)Semantic proximity Read ↗

Synthetic Nanobody-Functionalized Nanoparticles for Accelerated Development of Rapid, Accessible Detection of Viral AntigensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.